In laboratory settings, FOXO4-DRI is used as a research reagent for experimental systems examining FOXO4-p53 protein interaction disruption, senescent cell modeling, DNA damage signaling assays, and oxidative stress research
REDEFINE 2 documented smaller mean weight loss (13.7%) in a diabetes population than REDEFINE 1 (22.7% on-treatment) in a population without diabetes a pattern consistent across the incretin-therapy literature (Lingvay et al., 2025
Moreover, FOXO4-DRI was used to selectively induce apoptosis of senescent fibroblasts in both keloid fibroblast and organ culture senescent models, showing potential as a treatment that targets the senescence and apoptosis resistance observed in keloid fibroblasts
This causes you to urinate frequently
Cell surface markers, especially transport proteins and signaling receptors, have attracted considerable interest because of their potential to enhance diagnostic capabilities and enable the targeted delivery of therapeutic agents to CSCs [329]